David S. Mathai

410 total citations
23 papers, 265 citations indexed

About

David S. Mathai is a scholar working on Clinical Psychology, Pharmacology and Biological Psychiatry. According to data from OpenAlex, David S. Mathai has authored 23 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Psychology, 13 papers in Pharmacology and 6 papers in Biological Psychiatry. Recurrent topics in David S. Mathai's work include Psychedelics and Drug Studies (9 papers), Treatment of Major Depression (7 papers) and Cannabis and Cannabinoid Research (6 papers). David S. Mathai is often cited by papers focused on Psychedelics and Drug Studies (9 papers), Treatment of Major Depression (7 papers) and Cannabis and Cannabinoid Research (6 papers). David S. Mathai collaborates with scholars based in United States, Australia and United Kingdom. David S. Mathai's co-authors include Albert Garcia‐Romeu, Eric A. Storch, Thomas R. Kosten, Matthew J. Meyer, Sandeep M. Nayak, David B. Yaden, Nathan D. Sepeda, Minoru Tozuka, Justin C. Strickland and Roland R. Griffiths and has published in prestigious journals such as Scientific Reports, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

David S. Mathai

22 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Mathai United States 8 162 134 87 64 64 23 265
Sanne Y. Smith-Apeldoorn Netherlands 8 98 0.6× 184 1.4× 127 1.5× 62 1.0× 43 0.7× 18 304
Jolien K. E. Veraart Netherlands 11 124 0.8× 223 1.7× 156 1.8× 74 1.2× 53 0.8× 25 363
Anna Forsyth New Zealand 12 288 1.8× 98 0.7× 57 0.7× 141 2.2× 174 2.7× 27 502
Juliana Mendes Rocha Brazil 11 296 1.8× 117 0.9× 23 0.3× 113 1.8× 129 2.0× 19 355
Anna Borissova United Kingdom 10 70 0.4× 134 1.0× 23 0.3× 47 0.7× 15 0.2× 23 218
A. Y. Grinenko Russia 5 266 1.6× 291 2.2× 177 2.0× 225 3.5× 106 1.7× 8 512
Rayyan Zafar United Kingdom 9 92 0.6× 113 0.8× 16 0.2× 48 0.8× 34 0.5× 16 256
Justin M. Saunders United States 10 169 1.0× 26 0.2× 61 0.7× 187 2.9× 90 1.4× 12 371
Özden Merve Mollaahmetoğlu United Kingdom 4 84 0.5× 82 0.6× 52 0.6× 31 0.5× 27 0.4× 5 148
Sophia Armand Denmark 10 204 1.3× 25 0.2× 37 0.4× 115 1.8× 115 1.8× 21 331

Countries citing papers authored by David S. Mathai

Since Specialization
Citations

This map shows the geographic impact of David S. Mathai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Mathai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Mathai more than expected).

Fields of papers citing papers by David S. Mathai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Mathai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Mathai. The network helps show where David S. Mathai may publish in the future.

Co-authorship network of co-authors of David S. Mathai

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Mathai. A scholar is included among the top collaborators of David S. Mathai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Mathai. David S. Mathai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathai, David S., Sandeep M. Nayak, Nathan D. Sepeda, et al.. (2025). Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use. Journal of Psychoactive Drugs. 1–12. 3 indexed citations
2.
Mathai, David S., et al.. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports. 14(1). 28022–28022. 7 indexed citations
3.
4.
Mathai, David S.. (2024). Learning how to make use of dissociative therapies. International Review of Psychiatry. 36(8). 856–868. 1 indexed citations
5.
Guzick, Andrew G., Alison Salloum, Sarah M. Kennedy, et al.. (2024). Predictors of Treatment Outcome for Parent-Led, Transdiagnostic Cognitive Behavioral Therapy for Youth with Emotional Problems Related to the COVID-19 Pandemic. Child & Youth Care Forum. 53(5). 1125–1140. 1 indexed citations
6.
Mathai, David S., Sandeep M. Nayak, David B. Yaden, & Albert Garcia‐Romeu. (2023). Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine. Psychopharmacology. 240(4). 827–836. 25 indexed citations
7.
8.
Nayak, Sandeep M., Nathan D. Sepeda, David S. Mathai, et al.. (2023). Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14. 1199642–1199642. 45 indexed citations
9.
Guzick, Andrew G., Sophie C. Schneider, Sandra L. Cepeda, et al.. (2022). Brief, parent-led, transdiagnostic cognitive-behavioral teletherapy for youth with emotional problems related to the COVID-19 pandemic. Journal of Affective Disorders. 301. 130–137. 13 indexed citations
10.
Mathai, David S., David B. Yaden, & Kelley C. O’Donnell. (2022). The conundrum of therapeutic intoxication. The British Journal of Psychiatry. 221(2). 496–497. 4 indexed citations
11.
Mathai, David S., et al.. (2022). Toward Synergies of Ketamine and Psychotherapy. Frontiers in Psychology. 13. 868103–868103. 28 indexed citations
12.
Mathai, David S., et al.. (2022). Mapping consent practices for outpatient psychiatric use of ketamine. Journal of Affective Disorders. 312. 113–121. 9 indexed citations
13.
Mathai, David S., et al.. (2021). A qualitative inquiry of parents’ observations of their children’s mental health needs during the COVID-19 pandemic. Children s Health Care. 51(2). 213–234. 1 indexed citations
14.
Mathai, David S., Andrew G. Guzick, Sophie C. Schneider, et al.. (2021). Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and Suicidality. Journal of Child and Adolescent Psychopharmacology. 31(8). 553–561. 12 indexed citations
15.
Mathai, David S., et al.. (2020). Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Review of Neurotherapeutics. 20(10). 1029–1036. 7 indexed citations
16.
Mathai, David S., Matthew J. Meyer, Eric A. Storch, & Thomas R. Kosten. (2019). The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders. 264. 123–129. 63 indexed citations
17.
Mathai, David S., et al.. (2019). Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. American Journal on Addictions. 28(6). 455–464. 3 indexed citations
18.
19.
Mathai, David S., et al.. (2016). Paradoxical increase in synthetic cannabinoid emergency–related presentations after a citywide ban: Lessons from Houston, Texas. Bulletin of the Menninger Clinic. 80(4). 357–370. 1 indexed citations
20.
Mathai, David S., Noel Fidge, Minoru Tozuka, & A Mitchell. (1990). Regulation of hepatic high density lipoprotein binding proteins after administration of simvastatin and cholestyramine to rats.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 10(6). 1045–1050. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanne Y. Smith-Apeldoorn Breakdown of academic impact, for papers by Jolien K. E. Veraart Breakdown of academic impact, for papers by Anna Forsyth Breakdown of academic impact, for papers by Juliana Mendes Rocha Breakdown of academic impact, for papers by Anna Borissova Breakdown of academic impact, for papers by A. Y. Grinenko Breakdown of academic impact, for papers by Rayyan Zafar Breakdown of academic impact, for papers by Justin M. Saunders Breakdown of academic impact, for papers by Özden Merve Mollaahmetoğlu Breakdown of academic impact, for papers by Sophia Armand
Rankless by CCL
2026